About stryker corp. - SYK
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
SYK At a Glance
Stryker Corp.
1941 Stryker Way
Portage, Michigan 49002
| Phone | 1-269-385-2600 | Revenue | 22.60B | |
| Industry | Medical Specialties | Net Income | 2.99B | |
| Sector | Health Technology | 2024 Sales Growth | 10.23% | |
| Fiscal Year-end | 12 / 2025 | Employees | 53,000 | |
| View SEC Filings |
SYK Valuation
| P/E Current | 46.179 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 46.387 |
| Price to Sales Ratio | 6.145 |
| Price to Book Ratio | 6.655 |
| Price to Cash Flow Ratio | 32.73 |
| Enterprise Value to EBITDA | 24.294 |
| Enterprise Value to Sales | 6.571 |
| Total Debt to Enterprise Value | 0.095 |
SYK Efficiency
| Revenue/Employee | 426,320.755 |
| Income Per Employee | 56,471.698 |
| Receivables Turnover | 5.667 |
| Total Asset Turnover | 0.545 |
SYK Liquidity
| Current Ratio | 1.949 |
| Quick Ratio | 1.323 |
| Cash Ratio | 0.59 |
SYK Profitability
| Gross Margin | 61.872 |
| Operating Margin | 22.399 |
| Pretax Margin | 15.455 |
| Net Margin | 13.246 |
| Return on Assets | 7.222 |
| Return on Equity | 15.26 |
| Return on Total Capital | 8.612 |
| Return on Invested Capital | 9.494 |
SYK Capital Structure
| Total Debt to Total Equity | 68.431 |
| Total Debt to Total Capital | 40.628 |
| Total Debt to Total Assets | 32.859 |
| Long-Term Debt to Equity | 60.904 |
| Long-Term Debt to Total Capital | 36.16 |
Stryker Corp. in the News
Medical-device makers gain amid return to normalcy
Many of the top large-cap device makers reported relatively rosy fourth-quarter earnings while issuing 2023 guidance that was above analyst expectations.